Strides Pharma Science share news, announcements and annual reports
NSE: STARBSE: 532531Pharmaceuticals & BiotechnologySmall Cap
Strides Pharma Science Limited · Formerly Strides Shasun · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 2000 on NSE, Jun 2004 on BSE
Last close ₹1,036.90down ₹31.90 (2.98%)BSE ₹1,037.80
Share price at the NSE close on 2 Nov 2026. Previous close ₹1,068.80.
2 Nov: open ₹1,067.30, high ₹1,067.30, low ₹1,013.90
52-week range of traded prices to 2 Nov 2026
₹768.65Low, 29 Jan 2026₹1,260.90High, 21 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹9,557 Cr580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 15.50
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.80
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.48%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 20.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.53
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 4,07,98637.7% delivered
Strides Pharma Science shareholding disclosures
125 filed, newest first. Page 2 of 3.
Apr 2019
Jan 2019
29 Jan · Disclosure
Aug 2018
8 Aug · Disclosure
Apr 2018
6 Apr · Disclosure
Feb 2018
9 Feb · Disclosure
Oct 2017
31 Oct · Disclosure
Aug 2017
16 Aug · Disclosure
Jul 2017
20 Jul · Disclosure
Jun 2017
12 Jun · Disclosure
May 2017
18 May · Disclosure
Apr 2017
Mar 2017
17 Mar · Disclosure
Feb 2017
Oct 2016
Jun 2016
May 2016
Apr 2016
Nov 2015
Apr 2015
Mar 2015
Feb 2015
Jan 2015
Sep 2014
May 2014
Feb 2014
Dec 2013
Nov 2013
Oct 2013
Sep 2013
May 2013
Apr 2013
Mar 2013
Jan 2013
Nov 2012
Oct 2012
Sep 2012
Jul 2012
30 Jul · Disclosure
Remuneration Committee of the Company has granted 50,000 options to Mr. S Sridhar, Independent Director of the Company at Rs. 609.80 per option under the Strides Arcolab ESOP 2008 (Director) Scheme. The shares covered by such option are 50,000 equity shares of Rs.10/- each. The vesting period of these options is in a phased manner over a period of three years. The options may be exercised within a period of 30 days from the date of vesting.